Clinical Trials Browser

Phase 4 × Ranitidine × Tumor-Agnostic × Clear all

NCT03145012 2023-02-08

Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity

Phase 4 Completed

Neoplasms